zearalenone and Genital-Neoplasms--Female

The aim of the monitoring of zearalenone presence in the blood plasma of women with neoplastic lesions in the reproductive tract was to asses whether the phytosteride is noted in the patients blood and whether the correlation exists between its presence and the incidence of particular neoplasm. The presence of zearalenone or its metabolite--alpha-zearalenole, was noted in 13.51% of the examined women. In 60% of the patients with the confirmed presence of the xenobiotic it was noted in the lowest concentrations. These patients had neoplastic lesions of Carcinoma corpus uteri type.

Topics: Estrogens, Non-Steroidal; Female; Genital Neoplasms, Female; Humans; Medical Records; Mycotoxicosis; Poland; Retrospective Studies; Uterine Neoplasms; Zearalenone